The Deloitte Center for Health Solutions and the Deloitte Health Equity Institute conducted a survey on the COVID-19 vaccine in the US. The survey found that many consumers are hesitant to take the vaccine due to access, trust, and other barriers. The Deloitte Health Equity Institute aims to overcome these barriers by conducting original research and disseminating findings to drive data-based equitable outcomes and activate interventions that address systemic inequities. The institute is part of Deloitte LLP's Life Sciences and Health Care practice and research arm, and provides fresh perspectives on complex challenges in the health care industry.
